83 related articles for article (PubMed ID: 15959914)
1. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
[TBL] [Abstract][Full Text] [Related]
2. Does Adjuvant Therapy Benefit Low-Risk Resectable Cholangiocarcinoma? An Evaluation of the NCCN Guidelines.
Munir MM; Ruff SM; Endo Y; Lima HA; Alaimo L; Moazzam Z; Shaikh C; Pawlik TM
J Gastrointest Surg; 2023 Mar; 27(3):511-520. PubMed ID: 36538255
[TBL] [Abstract][Full Text] [Related]
3. Adenosquamous Carcinoma of the Extrahepatic Bile Duct.
Gupta D; Khera S; Soni SC
Ochsner J; 2022; 22(1):89-93. PubMed ID: 35355647
[No Abstract] [Full Text] [Related]
4. MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma.
Elahi M; Rakhshan V
Sci Rep; 2020 May; 10(1):8475. PubMed ID: 32439976
[TBL] [Abstract][Full Text] [Related]
5. Dual-organ invasion is associated with a lower survival rate than single-organ invasion distal bile duct cancer: A multicenter study.
Min KW; Kim DH; Son BK; Moon KM; Kim EK; Oh YH; Kwon MJ; Choi HS
Sci Rep; 2018 Jul; 8(1):10826. PubMed ID: 30018404
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma.
Jun SY; Sung YN; Lee JH; Park KM; Lee YJ; Hong SM
Cancer Res Treat; 2019 Jan; 51(1):98-111. PubMed ID: 29510611
[TBL] [Abstract][Full Text] [Related]
7. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
8. Validation of T Stage According to Depth of Invasion and N Stage Subclassification Based on Number of Metastatic Lymph Nodes for Distal Extrahepatic Bile Duct (EBD) Carcinoma.
Moon A; Choi DW; Choi SH; Heo JS; Jang KT
Medicine (Baltimore); 2015 Dec; 94(50):e2064. PubMed ID: 26683915
[TBL] [Abstract][Full Text] [Related]
9. Is it possible to define early distal cholangiocarcinoma?
Miura F; Sano K; Amano H; Toyota N; Wada K; Tokairin T; Kondo F; Hayano K; Matsubara H; Takada T
Langenbecks Arch Surg; 2016 Feb; 401(1):25-32. PubMed ID: 26518568
[TBL] [Abstract][Full Text] [Related]
10. Suggestions for improving perihilar cholangiocarcinoma staging based on an evaluation of the seventh edition AJCC system.
Kwon W; Jang JY; Chang YR; Jung W; Kang MJ; Kim SW
J Gastrointest Surg; 2015 Apr; 19(4):666-74. PubMed ID: 25572971
[TBL] [Abstract][Full Text] [Related]
11. Pancreaticobiliary maljunction is associated with common bile duct carcinoma: a meta-analysis.
Li Y; Wei J; Zhao Z; You T; Zhong M
ScientificWorldJournal; 2013; 2013():618670. PubMed ID: 24489507
[TBL] [Abstract][Full Text] [Related]
12. HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.
Lee HJ; Chung JY; Hewitt SM; Yu E; Hong SM
Virchows Arch; 2012 Nov; 461(5):521-30. PubMed ID: 23052372
[TBL] [Abstract][Full Text] [Related]
13. Hilar cholangiocarcinoma: tumor depth as a predictor of outcome.
de Jong MC; Hong SM; Augustine MM; Goggins MG; Wolfgang CL; Hirose K; Schulick RD; Choti MA; Anders RA; Pawlik TM
Arch Surg; 2011 Jun; 146(6):697-703. PubMed ID: 21690446
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of UICC-TNM and JSBS staging systems for surgical patients with extrahepatic cholangiocarcinoma.
Sasaki R; Murata S; Oda T; Ohkohchi N; Takeda Y; Wakabayashi G
Langenbecks Arch Surg; 2010 Aug; 395(6):615-23. PubMed ID: 20358381
[TBL] [Abstract][Full Text] [Related]
15. Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma.
Hong SM; Pawlik TM; Cho H; Aggarwal B; Goggins M; Hruban RH; Anders RA
Surgery; 2009 Aug; 146(2):250-7. PubMed ID: 19628081
[TBL] [Abstract][Full Text] [Related]
16. Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers.
Németh Z; Szász AM; Somorácz A; Tátrai P; Németh J; Gyorffy H; Szíjártó A; Kupcsulik P; Kiss A; Schaff Z
Pathol Oncol Res; 2009 Sep; 15(3):533-9. PubMed ID: 19184677
[TBL] [Abstract][Full Text] [Related]
17. The expression of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangiocarcinoma.
Chung JY; Hong SM; Choi BY; Cho H; Yu E; Hewitt SM
Clin Cancer Res; 2009 Jan; 15(2):660-7. PubMed ID: 19147772
[TBL] [Abstract][Full Text] [Related]
18. Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.
Németh Z; Szász AM; Tátrai P; Németh J; Gyorffy H; Somorácz A; Szíjártó A; Kupcsulik P; Kiss A; Schaff Z
J Histochem Cytochem; 2009 Feb; 57(2):113-21. PubMed ID: 18854598
[TBL] [Abstract][Full Text] [Related]
19. Adenosquamous carcinoma of extrahepatic bile duct: clinicopathologic study of 12 cases.
Hong SM; Kim MJ; Jang KT; Yoon GS; Cho H; Frierson HF; Yu E
Int J Clin Exp Pathol; 2008 Jan; 1(2):147-56. PubMed ID: 18784802
[TBL] [Abstract][Full Text] [Related]
20. Staging of extrahepatic cholangiocarcinoma.
Chung YE; Kim MJ; Park YN; Lee YH; Choi JY
Eur Radiol; 2008 Oct; 18(10):2182-95. PubMed ID: 18458911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
